FDA cleared–US only 🇺🇸
Sleep Rx
This innovative sleep tracking mat offers a non-invasive, contactless, at-home solution to aid in the diagnosis of Obstructive Sleep Apnea (OSA), addressing a critical health issue affecting millions. By providing detailed sleep analysis without the need for cumbersome equipment, Sleep Rx enhances diagnosis rates and ultimately improves long-term health outcomes.
Transform patient care with clinical-grade Withings AHI
100% contactless sensor to aid in the detection of sleep apnea
By calculating the Withings Apnea-Hypopnea Index (AHI) from the Sleep Rx data, the algorithm aids in the diagnosis and monitoring of Obstructive Sleep Apnea (OSA).
In-depth sleep analysis
Receive a comprehensive, lab-level breakdown of your participants’ sleep. We provide crucial data on sleep cycles, including the duration of deep, light, and REM sleep, alongside total duration and interruptions. For even richer insight, Sleep Rx uniquely identifies snoring patterns, separating them from environmental noises.
Effortless and unobtrusive
A simple, one-time setup under the participant's mattress provides automatic, continuous tracking with nothing to wear or charge, maximizing long-term patient adherence.
Internal study on Withings database
87% of sleep tracking mats are still being used after one year.
Tracked biomarkers
*FDA cleared
Features
Developed with sleep experts
Cellular connectivity via our Data Hub
One-time setup
Long-term user engagement
Compatible with all mattresses**
**Compatible with spring, foam, latex and memory foam layer mattresses. Tested on mattresses 4 to 15 inches (10 to 40 cm) thick.
Access to consistent and accurate health data has never been easier
Our remote monitoring platform is an easy tool to keep track of your patient cohort.
Sleep Analyzer seamlessly integrates into Withings RPM to allow you to take your sleep monitoring to the next level. The platform will allow you to retrieve all the sleep data for your cohort of patients.
Deliver the highest quality of care and avoid unnecessary complications.
Learn how partnerships improve health outcomes
Multinight prevalence, variability, and diagnostic misclassification of obstructive sleep apnea
Recent studies suggest that obstructive sleep apnea (OSA) severity can vary markedly from night to night, which may have important implications for diagnosis and management. This study looks at a total of 67,278 individuals aged between 18 and 90 years underwent in-home nightly monitoring over an average of approximately 170 nights per participant using the Withings Sleep Analyzer to examine the variation in OSA severity night to night.
Assessment of sleep patterns in dementia and general population cohorts using passive in-home monitoring technologies
Nocturnal disturbances are a common symptom experienced by people with dementia, and these often present prior to diagnosis. Imperial College London compared sleep data collected from both people with dementia and the general population using the Withings Sleep Analyzer to identify whether differences could be detected.
